Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

Purified Anti-Human CD39 Antibody[A1]

Product Sizes
25 ug
£80.00
E-AB-F11650P-25UG
100 ug
£118.00
E-AB-F11650P-100UG
1 mg
£309.00
E-AB-F11650P-1MG
5 mg
£1122.00
E-AB-F11650P-5MG
25 mg
£4290.00
E-AB-F11650P-25MG
50 mg
£7489.00
E-AB-F11650P-50MG
100 mg
£10688.00
E-AB-F11650P-100MG
About this Product
SKU:
E-AB-F11650P
Additional Names:
SPG;Ecto-ATP diphosphohydrolase;Ectonucleoside triphosphate diphosphohydrolase;ENTPD;ENTPD1;ATPDase;CD39;NTPDase-1;SPG64;CD 39;NTPDase1;Ecto-apyrase;Ectonucleoside triphosphate diphosphohydrolase 1;NTPDase 1;Ecto-ATP diphosphohydrolase 1;Lymphoid cell activation antigen; NTPDase-1;CD39 antigen;DKFZp686D194;DKFZp686I093;Ecto apyrase;Ecto ATP diphosphohydrolase;Ecto-ATPase 1;Ecto-ATPDase 1;ENTP1;ENTPD 1;FLJ40921;FLJ40959
Application:
Flow Cytometry
Buffer:
Phosphate-buffered solution, pH 7.2, containing 0.05% non-protein stabilizer. Dialyze to completely remove the stabilizer prior to labeling.
translate.label.attr.clone:
A1
Clonality:
Monoclonal
Concentration:
>= 1 mg/ml
Extra Details:
Ectonucleoside triphosphate diphosphohydrolase-1 (NTPDase-1) is an integral membrane protein with an extracellular active site. Recombinant human NTPDase-1 was expressed as a protein lacking its N- and C-terminal transmembrane domains, resulting in the secretion of the soluble recombinant human NTPDase-1 ectodomain.
Host:
Mouse
Immunogen:
CD39|Recombinant Human CD39 protein
Isotype:
IgG1, kappa
Purity:
>98%
Purification:
protein a/g purified
Reactivities:
Human
Shipping Conditions:
Blue Ice
Storage Conditions:
2-8[o]C Avoid freeze/thaw cycles., -20[o]C Avoid freeze/thaw cycles.
Supplier:
Elabscience
Type:
Antibody: Monoclonal Antibody
  • Manufacturer's Data Sheet:KpySh5
Human peripheral blood lymphocytes were stained with 0.2 ug AF/LE Purified Anti-Human CD279 Antibody[EH12.2H7] (Right) and 0.2 ug Mouse IgG1, K Kappa Isotype Control (Left), followed by Elab Fluor® 647-conjugated Goat Anti-Mouse IgG Secondary Antibody, then anti-Human CD3 PE-conjugated Monoclonal Antibody.
Human peripheral blood lymphocytes were stained with 0.2 ug AF/LE Purified Anti-Human CD279 Antibody[EH12.2H7] (Right) and 0.2 ug Mouse IgG1, K Kappa Isotype Control (Left), followed by Elab Fluor® 647-conjugated Goat Anti-Mouse IgG Secondary Antibody, then anti-Human CD3 PE-conjugated Monoclonal Antibody.
Human peripheral blood lymphocytes were stained with 0.2 ug Purified Anti-Human CD279 Antibody[EH12.2H7] (Right) and 0.2 ug Mouse IgG1, K Kappa Isotype Control (Left), followed by Elab Fluor® 647-conjugated Goat Anti-Mouse IgG Secondary Antibody, then anti-Human CD3 PE-conjugated Monoclonal Antibody.
Human peripheral blood lymphocytes were stained with 0.2 ug AF/LE Purified Anti-Human CD3 Antibody[UCHT1] (Right) and 0.2 ug Mouse IgG1, K Kappa Isotype Control (Left), followed by PE-conjugated Goat Anti-Mouse IgG Secondary Antibody.
Raji were stained with 0.2 ug AF/LE Purified Anti-Human CD80 Antibody[2D10] (Right) and 0.2 ug Mouse IgG1, K Kappa Isotype Control (Left), followed by Elab Fluor® 647-conjugated Goat Anti-Mouse IgG Secondary Antibody.